Skip to content

News Blog / Press

Adeona Executes Agreement to Initiate Phase IIB Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS)

Press coverage

This story was published by prnewswire.com.

Read the article
More newsAll news